Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like 2 Underappreciated Biotech Stocks to Buy in 2018 January 1, 2018 J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer February 14, 2018 Strongbridge Biopharma Announces New Employment Inducement Awards June 22, 2017
